Danish-German molecular biotechnologist. Cofounder of, coach, and article writer for Marchward. Co-developer of the Mosaic Method.
4 months of treatment with a pharmaceutical plan formulated to suppress IL-6 over-expression in one patient has shown first success. Continuation and reproducibility of the effect remain to be seen.
Merlin L. Marquard